126 related articles for article (PubMed ID: 23080366)
1. Acquired factor V inhibitor developing in a patient with esophageal squamous cell carcinoma.
Ahmadinejad M; Roushan N
Blood Coagul Fibrinolysis; 2013 Jan; 24(1):97-9. PubMed ID: 23080366
[TBL] [Abstract][Full Text] [Related]
2. An acquired factor V inhibitor associated with defective factor V function, storage and binding to multimerin 1.
Jeimy SB; Krakow EF; Fuller N; Tasneem S; Hayward CP
J Thromb Haemost; 2008 Feb; 6(2):395-7. PubMed ID: 18047547
[No Abstract] [Full Text] [Related]
3. A rare case of an acquired factor V inhibitor in a patient with myelodysplastic syndrome during azacitidine treatment.
Fujita Y; Nakazato T; Ito C; Masuda K; Osada Y; Aisa Y; Mori T
Ann Hematol; 2018 Oct; 97(10):2009-2010. PubMed ID: 29713749
[No Abstract] [Full Text] [Related]
4. High-titer acquired factor V inhibitor responsive to corticosteroids and cyclophosphamide in a patient with two malignant tumors.
Bayani N; Rugina M; Haddad-Vergnes L; Lelong F
Am J Hematol; 2002 Sep; 71(1):33-6. PubMed ID: 12221671
[TBL] [Abstract][Full Text] [Related]
5. Multimodality therapy of an acquired factor V inhibitor.
Fu YX; Kaufman R; Rudolph AE; Collum SE; Blinder MA
Am J Hematol; 1996 Apr; 51(4):315-8. PubMed ID: 8602633
[TBL] [Abstract][Full Text] [Related]
6. Acquired factor V deficiency in a patient with a urinary tract infection presenting with haematuria followed by multiple haemorrhages with an extremely low level of factor V inhibitor: a case report and review of the literature.
Wang X; Qin X; Yu Y; Wang R; Liu X; Ji M; Zhou M; Chen C
Blood Coagul Fibrinolysis; 2017 Jun; 28(4):334-341. PubMed ID: 27428013
[TBL] [Abstract][Full Text] [Related]
7. Factor VIII inhibitor associated with esophageal carcinoma.
Pereira DL; Phyliky RL; Nichols WL
Thromb Haemost; 2000 Apr; 83(4):635-6. PubMed ID: 10780335
[No Abstract] [Full Text] [Related]
8. Acquired factor V inhibitor in the setting of coronavirus disease 2019 infection.
Bennett J; Cunningham MT; Howard C; Hoffmann M; Plapp FV
Blood Coagul Fibrinolysis; 2021 Jun; 32(4):294-297. PubMed ID: 33443928
[TBL] [Abstract][Full Text] [Related]
9. Acquired factor V inhibitor in systemic vasculitis.
Ciang CO; Leung MH
Int J Rheum Dis; 2012 Apr; 15(2):e19-22. PubMed ID: 22462428
[No Abstract] [Full Text] [Related]
10. [Esophageal epidermoid carcinoma manifesting as a humoral, malignant hypercalcemia in a patient with cirrhosis].
Viguier J; Bronstein JA; Moulin O; Menecier D; Thiolet C; Farret O; Molinié C
Gastroenterol Clin Biol; 1998 Nov; 22(11):972-4. PubMed ID: 9881279
[No Abstract] [Full Text] [Related]
11. Development of cephradine-induced acquired factor V inhibitors: a case report.
Wu MT; Pei SN
Ann Pharmacother; 2010 Oct; 44(10):1673-6. PubMed ID: 20807866
[TBL] [Abstract][Full Text] [Related]
12. [Acrokeratosis paraneoplastica with bullous lesions associated with esophageal squamous cell carcinoma].
Cabanillas M; Pérez-Pérez L; Sánchez-Aguilar D; Fernández-Redondo V; Toribio J
Actas Dermosifiliogr; 2006 Apr; 97(3):196-9. PubMed ID: 16796967
[TBL] [Abstract][Full Text] [Related]
13. Generalized lichenoid dermatosis as a tumor-associated dermadrome in a patient with inoperable esophageal cancer.
Kato S; Takahara M; Shono A; Moroi Y; Furue M
Eur J Dermatol; 2011; 21(4):601-2. PubMed ID: 21659063
[No Abstract] [Full Text] [Related]
14. [Forty-eight year oldmale with dysphagia, general syndrome and finger clubbing].
Nuño Mateo FJ; Noval Menéndez J; Campoamor Serrano MT; Miranda Martínez E
Rev Clin Esp; 2003 Feb; 203(2):95-6. PubMed ID: 12605787
[No Abstract] [Full Text] [Related]
15. [Acquired haemophilia A: two cases].
de Vitry A; Valois A; Weinborn M; Dupuy-de Fonclare AL; Cuny JF; Barbaud A; Schmutz JL
Ann Dermatol Venereol; 2014; 141(6-7):441-5. PubMed ID: 24951143
[TBL] [Abstract][Full Text] [Related]
16. Multiple cutaneous nodules presenting as metastatic squamous cell carcinoma of the esophagus.
Levin J; Ogden L; Karnath B
Dermatol Online J; 2013 May; 19(5):18173. PubMed ID: 24011273
[TBL] [Abstract][Full Text] [Related]
17. Acquired factor V inhibitor and single exposure to autologous growth factor.
Shah AK; Moreno-Aspitia A
Thromb Res; 2005; 116(1):87-9. PubMed ID: 15850612
[No Abstract] [Full Text] [Related]
18. Severe bleeding caused by an inhibitor to coagulation factor V: a case report.
Smid WM; de Wolf JT; Nijland JH; Bom VJ; van der Meer J
Blood Coagul Fibrinolysis; 1994 Feb; 5(1):133-7. PubMed ID: 8180333
[TBL] [Abstract][Full Text] [Related]
19. Factor V inhibitors: rare or not so uncommon? A multi-laboratory investigation.
Favaloro EJ; Posen J; Ramakrishna R; Soltani S; McRae S; Just S; Aboud M; Low J; Gemmell R; Kershaw G; Coleman R; Dean M
Blood Coagul Fibrinolysis; 2004 Oct; 15(8):637-47. PubMed ID: 15613918
[TBL] [Abstract][Full Text] [Related]
20. Peroral esophageal intubation for obstructive carcinoma of the esophagus.
Lewis RJ; Kunderman PJ; Sisler GE; Mackenzie JW
S D J Med; 1973 Oct; 26(10):148-57. PubMed ID: 4126403
[No Abstract] [Full Text] [Related]
[Next] [New Search]
